{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:12:50Z","timestamp":1789236770490,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41401-025-01653-0","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T06:55:05Z","timestamp":1757400905000},"page":"419-433","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Long non-coding RNA STMN1P2 promotes breast cancer doxorubicin resistance by inhibiting pyroptosis through the hnRNPU-EZH2-TARF6-MALT1-caspase-1 pathway"],"prefix":"10.1038","volume":"47","author":[{"given":"You-ping","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bu-jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-fen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-ling","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-fu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-bai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"1653_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"1653_CR2","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.annonc.2023.08.017","volume":"34","author":"G Curigliano","year":"2023","unstructured":"Curigliano G, Burstein HJ, Gnant M, Loibl S, Cameron D, Regan MM, et al. Understanding breast cancer complexity to improve patient outcomes: the St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023. Ann Oncol. 2023;34:970\u201386.","journal-title":"Ann Oncol"},{"key":"1653_CR3","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.cell.2023.01.040","volume":"186","author":"E Nolan","year":"2023","unstructured":"Nolan E, Lindeman GJ, Visvader JE. Deciphering breast cancer: from biology to the clinic. Cell. 2023;186:1708\u201328.","journal-title":"Cell"},{"key":"1653_CR4","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 2013;13:714\u201326.","journal-title":"Nat Rev Cancer"},{"key":"1653_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"Y Wang","year":"2017","unstructured":"Wang Y, Gao W, Shi X, Ding J, Liu W, He H, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547:99\u2013103.","journal-title":"Nature"},{"key":"1653_CR6","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.7150\/thno.71086","volume":"12","author":"Z Rao","year":"2022","unstructured":"Rao Z, Zhu Y, Yang P, Chen Z, Xia Y, Qiao C, et al. Pyroptosis in inflammatory diseases and cancer. Theranostics. 2022;12:4310\u201329.","journal-title":"Theranostics"},{"key":"1653_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","volume":"6","author":"P Yu","year":"2021","unstructured":"Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X. Pyroptosis: mechanisms and diseases. Sig Transduct Target Ther. 2021;6:128.","journal-title":"Sig Transduct Target Ther"},{"key":"1653_CR8","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.7150\/ijbs.60292","volume":"17","author":"H Yan","year":"2021","unstructured":"Yan H, Luo B, Wu X, Guan F, Yu X, Zhao L, et al. Cisplatin induces pyroptosis via activation of MEG3\/NLRP3\/caspase-1\/GSDMD pathway in triple-negative breast cancer. Int J Biol Sci. 2021;17:2606\u201321.","journal-title":"Int J Biol Sci"},{"key":"1653_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22:96\u2013118.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1653_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100851","volume":"63","author":"D Singh","year":"2022","unstructured":"Singh D, Assaraf YG, Gacche RN. Long non-coding RNA mediated drug resistance in breast cancer. Drug Resist Updates. 2022;63:100851.","journal-title":"Drug Resist Updates"},{"key":"1653_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.semcancer.2020.06.019","volume":"72","author":"I Amelio","year":"2021","unstructured":"Amelio I, Bernassola F, Candi E. Emerging roles of long non-coding RNAs in breast cancer biology and management. Semin Cancer Biol. 2021;72:36\u201345.","journal-title":"Semin Cancer Biol"},{"key":"1653_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/19336918.2021.1921402","volume":"15","author":"L Li","year":"2021","unstructured":"Li L, Jin Y, Wang X, Wang L, Sun Y, Luo Y, et al. Long noncoding RNA ENST00000508435 promotes migration of breast cancer via FXR 1. Cell Adh Migr. 2021;15:140\u201351.","journal-title":"Cell Adh Migr"},{"key":"1653_CR13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0960-9776(03)00106-1","volume":"12","author":"KN Ogston","year":"2003","unstructured":"Ogston KN, Miller ID, Payne S, Hutcheon AW, Sarkar TK, Smith I, et al. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast. 2003;12:320\u20137.","journal-title":"Breast"},{"key":"1653_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep07548","volume":"4","author":"H Yun","year":"2014","unstructured":"Yun H, Shi R, Yang Q, Zhang X, Wang Y, Zhou X, et al. Over expression of hRad9 protein correlates with reduced chemosensitivity in breast cancer with administration of neoadjuvant chemotherapy. Sci Rep. 2014;4:7548.","journal-title":"Sci Rep"},{"key":"1653_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13045-022-01345-w","volume":"15","author":"X Wang","year":"2022","unstructured":"Wang X, Chen T, Li C, Li W, Zhou X, Li Y, et al. CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR. J Hematol Oncol. 2022;15:122.","journal-title":"J Hematol Oncol"},{"key":"1653_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.142","volume":"7","author":"X-H Liao","year":"2016","unstructured":"Liao XH, Wang JG, Li LY, Zhou DM, Ren KH, Jin YT, et al. Long intergenic non-coding RNA APOC1P1-3 inhibits apoptosis by decreasing \u03b1-tubulin acetylation in breast cancer. Cell Death Dis. 2016;7:e2236.","journal-title":"Cell Death Dis"},{"key":"1653_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature18629","volume":"535","author":"X Liu","year":"2016","unstructured":"Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H, et al. Inflammasome - activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016;535:153\u20138.","journal-title":"Nature"},{"key":"1653_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","volume":"42","author":"J Shi","year":"2017","unstructured":"Shi J, Gao W, Shao F. Pyroptosis: Gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 2017;42:245\u201354.","journal-title":"Trends Biochem Sci"},{"key":"1653_CR19","doi-asserted-by":"publisher","first-page":"e0145404","DOI":"10.1371\/journal.pone.0145404","volume":"10","author":"C Westbom","year":"2015","unstructured":"Westbom C, Thompson JK, Leggett A, MacPherson M, Beuschel S, Pass H, et al. Inflammasome modulation by chemotherapeutics in malignant mesothelioma. PLoS One. 2015;10:e0145404.","journal-title":"PLoS One"},{"key":"1653_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-1-62703-523-1_7","volume":"1040","author":"M Rayamajhi","year":"2013","unstructured":"Rayamajhi M, Zhang Y, Miao E. Detection of pyroptosis by measuring released lactate dehydrogenase activity. Methods Mol Biol. 2013;1040:85\u201390.","journal-title":"Methods Mol Biol"},{"key":"1653_CR21","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41580-023-00694-9","volume":"25","author":"J Ferrer","year":"2024","unstructured":"Ferrer J, Dimitrova N. Transcription regulation by long non-coding RNAs: mechanisms and disease relevance. Nat Rev Mol Cell Biol. 2024;25:396\u2013415.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1653_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6323","volume":"5","author":"PK Puvvula","year":"2014","unstructured":"Puvvula PK, Desetty RD, Pineau P, Marchio A, Moon A, Dejean A, et al. Long noncoding RNA PANDA and scaffold-attachment-factor SAFA control senescence entry and exit. Nat Commun. 2014;5:5323.","journal-title":"Nat Commun"},{"key":"1653_CR23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41588-018-0338-y","volume":"51","author":"MC Donaldson-Collier","year":"2019","unstructured":"Donaldson-Collier MC, Sungalee S, Zufferey M, Tavernari D, Katanayeva N, Battistello E, et al. EZH2 oncogenic mutations drive epigenetic, transcriptional, and structural changes within chromatin domains. Nat Genet. 2019;51:517\u201328.","journal-title":"Nat Genet"},{"key":"1653_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.7150\/thno.46360","volume":"11","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Xiang C, Zhong F, Zhang Y, Wang L, Zhao Y, et al. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis. Theranostics. 2021;11:361\u201378.","journal-title":"Theranostics"},{"key":"1653_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1012-0","volume":"9","author":"X Zhou","year":"2018","unstructured":"Zhou X, Zang X, Guan Y, Tolbert T, Zhao TC, Bayliss G, et al. Targeting enhancer of zeste homolog 2 protects against acute kidney injury. Cell Death Dis. 2018;9:1067.","journal-title":"Cell Death Dis"},{"key":"1653_CR26","first-page":"E3796","volume":"114","author":"Y Liu","year":"2017","unstructured":"Liu Y, Peng J, Sun T, Li N, Zhang L, Ren J, et al. Epithelial EZH2 serves as an epigenetic determinant in experimental colitis by inhibiting TNF\u03b1-mediated inflammation and apoptosis. Proc Natl Acad Sci USA. 2017;114:E3796\u2013805.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1653_CR27","doi-asserted-by":"crossref","unstructured":"Lan P, Fan Y, Zhao Y, Lou X, Monsour HP, Zhang X, et al. TNF superfamily receptor OX40 triggers invariant NKT cell pyroptosis and liver injury. J Clin Invest. 127;127:2222\u201334.","DOI":"10.1172\/JCI91075"},{"key":"1653_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-018-0605-x","volume":"11","author":"C He","year":"2019","unstructured":"He C, Sun J, Liu C, Jiang Y, Hao Y. Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin. Clin Epigenet. 2019;11:8.","journal-title":"Clin Epigenet"},{"key":"1653_CR29","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/cac2.12207","volume":"41","author":"S Lei","year":"2021","unstructured":"Lei S, Zheng R, Zhang S, Wang S, Chen R, Sun K, et al. Global patterns of breast cancer incidence and mortality: a population\u2010based cancer registry data analysis from 2000 to 2020. Cancer Commun. 2021;41:1183\u201394.","journal-title":"Cancer Commun"},{"key":"1653_CR30","doi-asserted-by":"publisher","first-page":"594","DOI":"10.6004\/jnccn.2023.0031","volume":"21","author":"WJ Gradishar","year":"2023","unstructured":"Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, et al. NCCN Guidelines\u00ae insights: breast cancer, version 4.2023: featured updates to the NCCN guidelines. J Natl Compr Cancer Netw. 2023;21:594\u2013608.","journal-title":"J Natl Compr Cancer Netw"},{"key":"1653_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5939-z","volume":"19","author":"C Christowitz","year":"2019","unstructured":"Christowitz C, Davis T, Isaacs A, van Niekerk G, Hattingh S, Engelbrecht AM. Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model. BMC Cancer. 2019;19:757.","journal-title":"BMC Cancer"},{"key":"1653_CR32","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ctrv.2008.01.007","volume":"34","author":"HM Coley","year":"2008","unstructured":"Coley HM. Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer. Cancer Treat Rev. 2008;34:378\u201390.","journal-title":"Cancer Treat Rev"},{"key":"1653_CR33","doi-asserted-by":"publisher","first-page":"10360","DOI":"10.7150\/thno.49922","volume":"10","author":"L Peng","year":"2020","unstructured":"Peng L, Jiang J, Tang B, Nice EC, Zhang YY, Xie N. Managing therapeutic resistance in breast cancer: from the lncRNAs perspective. Theranostics. 2020;10:10360\u201377.","journal-title":"Theranostics"},{"key":"1653_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01975-3","volume":"23","author":"F Luo","year":"2024","unstructured":"Luo F, Zhang M, Sun B, Xu C, Yang Y, Zhang Y, et al. LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1\/PLK3\/HIF1\u03b1 signaling. Mol Cancer. 2024;23:60.","journal-title":"Mol Cancer"},{"key":"1653_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01299-y","volume":"20","author":"F Zhang","year":"2021","unstructured":"Zhang F, Wang H, Yu J, Yao X, Yang S, Li W, et al. LncRNA CRNDE attenuates chemoresistance in gastric cancer via SRSF6-regulated alternative splicing of PICALM. Mol Cancer. 2021;20:6.","journal-title":"Mol Cancer"},{"key":"1653_CR36","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/17425255.2021.1887139","volume":"17","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wang Y, Qin Z, Cai S, Yu L, Hu H, et al. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer. Expert Opin Drug Metab Toxicol. 2021;17:291\u2013306.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1653_CR37","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","volume":"18","author":"RW Robey","year":"2018","unstructured":"Robey RW, Pluchino KM, Hall MD, Fojo AT, Bates SE, Gottesman MM. Revisiting the role of efflux pumps in multidrug-resistant cancer. Nat Rev Cancer. 2018;18:452\u201364.","journal-title":"Nat Rev Cancer"},{"key":"1653_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.189024","volume":"1878","author":"A Gieleci\u0144ska","year":"2023","unstructured":"Gieleci\u0144ska A, Kciuk M, Yahya EB, Ainane T, Mujwar S, Kontek R. Apoptosis, necroptosis, and pyroptosis as alternative cell death pathways induced by chemotherapeutic agents? Biochim Biophys Acta Rev Cancer. 2023;1878:189024.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1653_CR39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.trsl.2022.05.001","volume":"248","author":"B Ye","year":"2022","unstructured":"Ye B, Shi X, Xu J, Dai S, Xu J, Fan X, et al. Gasdermin D mediates doxorubicin-induced cardiomyocyte pyroptosis and cardiotoxicity via directly binding to doxorubicin and changes in mitochondrial damage. Transl Res. 2022;248:36\u201350.","journal-title":"Transl Res"},{"key":"1653_CR40","doi-asserted-by":"publisher","first-page":"8159","DOI":"10.1111\/jcmm.16574","volume":"25","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Zhang H, Li D, Zhou X, Qin Q, Zhang Q. Caspase\u20103\u2010mediated GSDME induced pyroptosis in breast cancer cells through the ROS\/JNK signalling pathway. J Cell Mol Med. 2021;25:8159\u201368.","journal-title":"J Cell Mol Med"},{"key":"1653_CR41","first-page":"596","volume":"31","author":"Y JIN","year":"2021","unstructured":"Jin Y, Li L, Zhou P. A study on the role of long non-coding RNA STMN1P2 in breast cancer and its mechanism. China Oncol. 2021;31:596\u2013604.","journal-title":"China Oncol"},{"key":"1653_CR42","doi-asserted-by":"publisher","first-page":"27974","DOI":"10.1074\/jbc.M109.037929","volume":"284","author":"M Ameyar-Zazoua","year":"2009","unstructured":"Ameyar-Zazoua M, Souidi M, Fritsch L, Robin P, Thomas A, Hamiche A, et al. Physical and functional interaction between heterochromatin protein 1\u03b1 and the RNA-binding protein heterogeneous nuclear ribonucleoprotein U. J Biol Chem. 2009;284:27974\u20139.","journal-title":"J Biol Chem"},{"key":"1653_CR43","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1038\/s41388-018-0128-0","volume":"37","author":"W Jiao","year":"2018","unstructured":"Jiao W, Chen Y, Song H, Li D, Mei H, Yang F, et al. HPSE enhancer RNA promotes cancer progression through driving chromatin looping and regulating hnRNPU\/p300\/EGR1\/HPSE axis. Oncogene. 2018;37:2728\u201345.","journal-title":"Oncogene"},{"key":"1653_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04118-4","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun Y, Ren D, Zhou Y, Shen J, Wu H, Jin X. Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1\/EZH2 complex in pancreatic cancer. Cell Death Dis. 2021;12:878.","journal-title":"Cell Death Dis"},{"key":"1653_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abl7895","volume":"15","author":"L Su","year":"2023","unstructured":"Su L, Chen Y, Huang C, Wu S, Wang X, Zhao X, et al. Targeting Src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models. Sci Transl Med. 2023;15:eabl7895.","journal-title":"Sci Transl Med"},{"key":"1653_CR46","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13046-023-02834-7","volume":"42","author":"P Su","year":"2023","unstructured":"Su P, Mao X, Ma J, Huang L, Yu L, Tang S, et al. ERR\u03b1 promotes glycolytic metabolism and targets the NLRP3\/caspase-1\/GSDMD pathway to regulate pyroptosis in endometrial cancer. J Exp Clin Cancer Res. 2023;42:274.","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01653-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01653-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01653-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T15:02:29Z","timestamp":1768575749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01653-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1653"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01653-0","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}